[Ip-health] WIPO General Assembly 2019: Opening statement of Knowledge Ecology International

Thiru Balasubramaniam thiru at keionline.org
Tue Oct 1 13:23:26 PDT 2019


keionline.org/31786

WIPO General Assembly 2019: Opening statement of Knowledge Ecology
International

Posted on October 1, 2019 by Thiru

On Tuesday, 1 October 2019, Knowledge Ecology International delivered the
following opening statement at the 2019 WIPO General Assembly.

________________________________

Thank you Chair.

KEI opposes any further work at the SCCR on a broadcast treaty, given the
confusion over the objectives of the treaty, and in particular, proposals
to provide effective perpetual rights to broadcasters for content that they
do not create, own or license, including works where there is no underlying
copyright or where the copyright holders have not been paid and/or license
their works for use by the public at no cost, such as under creative
commons licenses. KEI also notes that the SCCR work on broadcasting is
deeply uninformed as to the exploding role of new Internet streaming
technologies that feature encryption, require payments from users, and for
which the most important are controlled by very large multinational
technology companies, such as Google’s Youtube TV platform, Netflix,
Spotify, and Amazon Prime rather than locally owned broadcast entities. Why
would you want to give these companies intellectual property rights in
someone else’s creative works? Because, that will be the predictable
outcome of any new intellectual property right for broadcasting that
includes transmissions delivered at the time and choosing of the user.

As part of WIPO’s ongoing work on patents and health, KEI proposes that the
Standing Committee on the Law of Patents (SCP) discuss the role of patents
in the development of and access to new cell and gene therapies, such as
CAR T treatments for cancer, or gene therapies such as Luxturna or
Zolgensma. Among the topics to be considered are the extent to which patent
exceptions for the treatment of humans apply, as well as the high costs and
anti-competitive nature of licensing the emerging thickets of patents for
these treatments.


-- 
Thiru Balasubramaniam
Geneva Representative
Knowledge Ecology International
41 22 791 6727
thiru at keionline.org


More information about the Ip-health mailing list